Discover how new global guidelines aim to combat the rising threat of Candida infections with updated treatments and ...

The new guidelines provide updated diagnostic and therapeutic strategies for both mucocutaneous and invasive candidiasis.

Medically reviewed by Edmund Khoo, DDS Thrush, or oral candidiasis, is a fungal infection in your mouth and throat. It is ...

A 5-year study of bimekizumab in ankylosing spondylitis encountered no new safety signals, with efficacy sustained even in a conservative analysis with non-responder imputation, according to data ...

The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in Q3 of 2025.Four presentations for SCY-247 were accepted ...

Investment analysts at Brookline Capital Management issued their FY2029 EPS estimates for shares of SCYNEXIS in a report issued on Thursday, March 13th. Brookline Capital Management analyst K.

Further information The NICE-Wide Prioritisation Board have agreed that a Technology Appraisal (TA) would not be appropriate for this product and recommended that it is not selected for evaluation.

In a study set to be published in Mycology, a research team led by Prof. Jianping Xu from McMaster University and researcher Jinyan Wu from Hainan Medical University presents new findings on Candida ...